×
About 8,125 results

ALLMedicine™ Candidiasis Center

Research & Reviews  2,291 results

Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata
https://clinicaltrials.gov/ct2/show/NCT05398809

Aug 5th, 2022 - Study Description: This is a phase 2 open-label study to evaluate the efficacy and safety of the Janus-associated kinase (JAK) inhibitor, ruxolitinib, in severe APECED-associated alopecia areata (AA). Following an 8-wee observation period to asses...

Evaluation of cytokine profile in cervicovaginal lavage specimens of women having asymp...
https://doi.org/10.1080/01443615.2022.2106555
Journal of Obstetrics and Gynaecology : the Journal of Th... Aranha C, Goriwale M et. al.

Aug 4th, 2022 - Reproductive tract infections (RTIs) such as vaginal candidiasis and bacterial vaginosis (BV) are common among sexually active women and can be both symptomatic or asymptomatic. The microbiota of the reproductive tract triggers immune response at ...

Oteseconazole (Vivjoa) for recurrent vulvovaginal candidiasis.
https://www.ncbi.nlm.nih.gov/pubmed/35921077
The Medical Letter on Drugs and Therapeutics;

Aug 4th, 2022 - Oteseconazole (Vivjoa) for recurrent vulvovaginal candidiasis.|2022||

Studies of Disorders With Increased Susceptibility to Fungal Infections
https://clinicaltrials.gov/ct2/show/NCT01222741

Aug 1st, 2022 - This study is designed for the evaluation, diagnosis, and long-term follow up of selected patients with primary immune deficiencies and other conditions associated with fungal, and more specifically with Candida spp. infections. The primary immune...

The Effect of Probiotics on Maintenance of Health in Pregnancy and Infants
https://clinicaltrials.gov/ct2/show/NCT03310853

Aug 1st, 2022 - Throughout pregnancy women undergo many biological changes, including alterations in their microbiota. These infections can exacerbate pregnancy complications and increase the risk of preeclampsia and preterm birth. The present study aims to evalu...

see more →

Guidelines  9 results

British HIV Association/British Infection Association guidelines on the management of o...
https://doi.org/10.1111/hiv.12806
HIV Medicine 7 References; Dockrell DH, O’Shea D et. al.

Nov 2nd, 2019 - British HIV Association/British Infection Association guidelines on the management of opportunistic infection in people living with HIV: The clinical management of Candidiasis 2019.|2019|Dockrell DH,O’Shea D,Cartledge JD,Freedman AR,|diagnosis,dru...

Microbiological Laboratory Testing in the Diagnosis of Fungal Infections in Pulmonary a...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727169
American Journal of Respiratory and Critical Care Medicine; Hage CA, Carmona EM et. al.

Aug 31st, 2019 - Background: Fungal infections are of increasing incidence and importance in immunocompromised and immunocompetent patients. Timely diagnosis relies on appropriate use of laboratory testing in susceptible patients.Methods: The relevant literature r...

ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormyc...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394968
Haematologica Tissot F, Agrawal S et. al.

Dec 25th, 2016 - The European Conference on Infections in Leukemia (ECIL) provides recommendations for diagnostic strategies and prophylactic, pre-emptive or targeted therapy strategies for various types of infection in patients with hematologic malignancies or he...

Managing xerostomia and salivary gland hypofunction: executive summary of a report from...
https://doi.org/10.14219/jada.2014.44
Journal of the American Dental Association (1939); Plemons JM, Al-Hashimi I et. al.

Aug 2nd, 2014 - Xerostomia, also known as "dry mouth," is a common but frequently overlooked condition that is typically associated with salivary gland hypofunction, which is the objective measurement of reduced salivary flow. Patients with dry mouth exhibit symp...

Intra-abdominal candidiasis: the guidelines-forgotten non-candidemic invasive candidiasis.
https://doi.org/10.1007/s00134-013-3134-2
Intensive Care Medicine; Montravers P, Dupont H et. al.

Oct 25th, 2013 - Intra-abdominal candidiasis: the guidelines-forgotten non-candidemic invasive candidiasis.|2013|Montravers P,Dupont H,Eggimann P,|therapeutic use,drug effects,drug therapy,microbiology,drug therapy,microbiology,

see more →

Drugs  442 results see all →

Clinicaltrials.gov  247 results

Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata
https://clinicaltrials.gov/ct2/show/NCT05398809

Aug 5th, 2022 - Study Description: This is a phase 2 open-label study to evaluate the efficacy and safety of the Janus-associated kinase (JAK) inhibitor, ruxolitinib, in severe APECED-associated alopecia areata (AA). Following an 8-wee observation period to asses...

Studies of Disorders With Increased Susceptibility to Fungal Infections
https://clinicaltrials.gov/ct2/show/NCT01222741

Aug 1st, 2022 - This study is designed for the evaluation, diagnosis, and long-term follow up of selected patients with primary immune deficiencies and other conditions associated with fungal, and more specifically with Candida spp. infections. The primary immune...

The Effect of Probiotics on Maintenance of Health in Pregnancy and Infants
https://clinicaltrials.gov/ct2/show/NCT03310853

Aug 1st, 2022 - Throughout pregnancy women undergo many biological changes, including alterations in their microbiota. These infections can exacerbate pregnancy complications and increase the risk of preeclampsia and preterm birth. The present study aims to evalu...

Ibrexafungerp for the Treatment of Complicated Vulvovaginal Candidiasis
https://clinicaltrials.gov/ct2/show/NCT05399641

Jul 29th, 2022 - This study will treat subjects with complicated VVC who have failed prior fluconazole therapy with Ibrexafungerp for 1, 3 or 7 days of treatment. Approximately 150 eligible subjects will be enrolled. Subjects will be randomized to receive oral ibr...

Candida PCR Diagnosis Strategy in Patients From Intensive Care Units
https://clinicaltrials.gov/ct2/show/NCT04874441

Jul 28th, 2022 - Invasive candidiasis is a serious infection caused by yeasts of the genus Candida sp. Their incidence is increasing, particularly in intensive care. The prognosis is severe and depends on the early initiation of adequate antifungal treatment. At p...

see more →

News  258 results

A New Approach to an Old Problem: Not Just the Azoles for Vulvovaginal Candidiasis
https://www.mdedge.com/obgyn/article/252093/new-approach-old-problem-not-just-azoles-vulvovaginal-candidiasis

May 2nd, 2022 - At the conclusion of this activity, the participant will be able to: • Appreciate the scope of the problem of Candida infection in terms of cost, lost productivity, and medical visits • Learn current diagnostic and treatment patterns for vulvovagi.

FDA Approves Oteseconazole for Chronic Yeast Infections
https://www.medscape.com/viewarticle/972882

Apr 28th, 2022 - The US Food and Drug Administration (FDA) has approved oteseconazole capsules (Vivjoa), an azole antifungal agent for the prevention of recurrent yeast infections in females who are not of reproductive potential. Oteseconazole inhibits CYP51, an e...

Erythematous Plaque on the Groin and Buttocks
https://www.mdedge.com/dermatology/article/254176/infectious-diseases/erythematous-plaque-groin-and-buttocks
Leandro L. Leite, MD, MSc, Renato M. Bakos, MD, PhD

Apr 27th, 2022 - The Diagnosis: Pseudomonas Pyoderma A skin swab confirmed the presence of a ciprofloxacinsusceptible Pseudomonas aeruginosa strain. Our patient received oral ciprofloxacin 500 mg twice daily for 10 days with remarkable clinical improvement.

Review of New Drugs That May Be Used During Pregnancy
https://www.medscape.com/viewarticle/972789

Apr 27th, 2022 - In 2021, the Food and Drug Administration approved 50 new drugs, but 24 will not be described here because they would probably not be used in pregnancy. The 24 are Aduhelm (aducanumab) to treat Alzheimer’s disease; Azstarys (serdexmethylphenidate ...

FDA Approves Generic Symbicort for Asthma, COPD
https://www.medscape.com/viewarticle/970360

Mar 16th, 2022 - The US Food and Drug Administration (FDA) approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate) inhalation aerosol for the treatment of asthma in patients 6 years of age and older and for the maintenance treatment ...

see more →

Patient Education  3 results see all →